» Articles » PMID: 29524499

CT Angiography for One-year Follow-up of Intracranial Aneurysms Treated with the WEB Device: Utility in Evaluating Aneurysm Occlusion and WEB Compression at One Year

Overview
Journal J Neuroradiol
Specialties Neurology
Radiology
Date 2018 Mar 11
PMID 29524499
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: The WEB is an innovative flow disruption device for cerebral aneurysm embolization with rapidly expanding indications. Our purpose was to evaluate the diagnostic performance of computed tomography angiography (CTA) at 1-year follow-up of aneurysms treated with the WEB.

Materials And Methods: Between April 2014 and May 2016, the study prospectively included patients treated with the WEB at our institution, and followed up within 24hours by CTA and at 1year by CTA, time-of-flight magnetic resonance angiography (TOF MRA) and digital subtraction angiography (DSA). The diagnostic quality of imaging data was assessed based on the confidence index, artifacts, and WEB shape depiction. The imaging diagnostic performance was assessed using 3 criteria at 1year: aneurysm occlusion status and worsening, and WEB shape compression. Interobserver and intermodality agreement was determined by calculating κ values.

Results: The study ultimately included 16 patients (9 women, mean age 53±7.6years). CTA quality confidence was scored as 2/2, artifacts 0.4/2 and WEB shape depiction 1.9/2, superior to TOF MRA for the latter two criteria. Aneurysm occlusion was adequate in 93.7% of patients, with CTA showing excellent interobserver reproducibility and agreement with DSA on a 4-grade scale (κ=1.00), while TOF MRA yielded good reproducibility (κ=0.76) and agreement with DSA (κ=0.69). CTA also identified aneurysm occlusion worsening (43.7%) and WEB compression (81.2%) in excellent agreement with DSA (κ=0.85 and 1.00).

Conclusions: CTA is a reproducible and reliable technique for the follow-up of aneurysms treated with the WEB device.

Citing Articles

Reliability and applicability of angiographic outcome scales in WEB device-treated aneurysms: a systematic review.

Comby P, Finitsis S, Iancu D, Alexandratou M, Benomar A, Roy D Neuroradiology. 2024; 67(1):191-199.

PMID: 39704797 DOI: 10.1007/s00234-024-03526-5.


Non-invasive follow-up for intracranial aneurysms treated with contour neurovascular system-comparison of digital subtraction angiography (DSA) to magnetic resonance imaging (MRI) and spectral computed tomography angiography (CTA) in vitro.

Madjidyar J, Pravdivtseva M, Hensler J, Jansen O, Larsen N, Wodarg F Interv Neuroradiol. 2024; :15910199241277907.

PMID: 39219551 PMC: 11569776. DOI: 10.1177/15910199241277907.


Endovascular Treatment of Bifurcation Aneurysms with the Woven EndoBridge: Product Features and Selected Results of Off-Label Use.

Teranishi K, Ikemura R, Arai S, Mitome-Mishima Y, Kitamura T, Kondo A J Neuroendovasc Ther. 2024; 18(3):65-74.

PMID: 38559453 PMC: 10973567. DOI: 10.5797/jnet.ra.2023-0086.


Persistent Opacification of the Woven EndoBridge Device: A Conebeam CT Analysis of the Bicêtre Occlusion Scale Score 1 Phenomenon.

Caroff J, Popescu S, Mihalea C, Popica D, Ikka L, Gallas S AJNR Am J Neuroradiol. 2023; 44(3):291-296.

PMID: 36759143 PMC: 10187822. DOI: 10.3174/ajnr.A7783.


Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up.

Pierot L, Szikora I, Barreau X, Holtmannspoetter M, Spelle L, Klisch J J Neurointerv Surg. 2022; 15(6):552-557.

PMID: 35803731 PMC: 10314010. DOI: 10.1136/neurintsurg-2021-018414.